Egypt HIV country profile

Sociodemographic data

  • Total population (in millions): 93.4
  • Maternal mortality per 100 000 live births :33
  • Life expectancy at birth (years) : 71
  • Total fertility rate (births per woman) : 3.4
  • GNI per capita, PPP (current international US$) :10 710
  • Health expenditure, total (% of GDP) : 5.6
  • Health expenditure per capita (current US$) : 178
  • Human Development Index Value: 0.6

HIV care cascade and progress towards 90-90-90

Fig_1._Afghanistan

Epidemiological data (2016)

HIV estimates and case notification

 

Estimated

Reported

HIV prevalence in general population

<0.1 [<0.1 - <0.1]

NA

People living with HIV (PLHIV)

11,000

 

New infections

1600

 

AIDS-related deaths

<500 (319)

NA

 

 

 

Egypt_fig_2

 

 

HIV in specific populations

 

Survey data

 

Size estimate

Routine testing and VCT data

Key populations

 

 

 

No tested

HIV+ cases (%)

Sex workers (SW)

0.8% (2006 Cairo)

0% (2010 Cairo)

 

23,000

184

1.1% (2015)

Men having sex with men (MSM)

6.2% (2006 Alex)

6.9% (2006 Alex)

 

64,000

954

2.4% (2015)

People who inject drugs (PWIDs)

0.6 (2006 in Cairo) 6.5% (2010 in Alex)

 

93,000

2174

2.4% (2015)

Prisoners

1.1 (2012)

 

 

 

 

Populations in health settings

 

 

 

 

 

TB patients

<.001 (2009)

 

 

413

0.2% (2015)

Pregnant women

 

 

 

 

 

Blood donors

 

 

 

 

 

Clients of testing services

 

 

 

 

 

Response

Policy implementation

 

 

 

Implementation of national policy on HIV self-testing (HIVST)

Unknown

Treatment initiation threshold adults and adolescents

 

≤500 CD4 cells/mm3

Implementation of Treat All adults and adolescents

 

Recommending Treat All later in 2017

Treatment initiation threshold children

 

Treat All, with an age cut-off <5 years

Implementation of lifelong ART to pregnant & breastfeeding women

Implemented countrywide

Implementation of national policy on viral load monitoring

 

Fully implemented

HIV testing coverage in key populations *

Egypt_fig_3

Antiretroviral therapy and PMTCT coverage

Egypt_fig_4

References 

(1) http://www.prb.org/pdf16/prb-wpds2016-web-2016.pdf; (2) WHO.EMRO Regional Surveillance Data; (3) WHO/UNAIDS data spectrum 2016; (4) Global AIDS Monitoring (GAM) 2016.